NASDAQ:CBIO Crescent Biopharma Q3 2026 Earnings Results & Report $12.84 +0.44 (+3.51%) As of 02:47 PM Eastern This is a fair market value price provided by Massive. Learn more. Crescent Biopharma missed analyst earnings expectations but beat on revenue in its Q3 2026 results, released November 12, 2026. The company reported EPS of -$0.90 versus the -$0.6954 consensus estimate, while revenue of $3.12 million topped the $625 thousand estimate by $2.49 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 12, 2026TimeAfter Market Closes Crescent Biopharma EPS ResultsActual EPS-$0.90Consensus EPS -$0.6954Beat/MissMissed by -$0.2046One Year Ago EPSN/AEPS Beat Rate3 of last 8 quartersCrescent Biopharma Revenue ResultsActual Revenue$3.12 millionExpected Revenue$625 thousandBeat/MissBeat by +$2.49 millionYoY Revenue GrowthN/AConference Call ResourcesSEC FilingEarnings HistoryCompany Profile Crescent Biopharma Q3 2026 Earnings FAQ Did Crescent Biopharma beat earnings estimates for Q3 2026? Crescent Biopharma (NASDAQ:CBIO) reported earnings of -$0.90 per share for Q3 2026, missing the consensus estimate of -$0.6954. The report was announced on Thursday, November 12, 2026. What was Crescent Biopharma's revenue for Q3 2026? Crescent Biopharma reported revenue of $3.12 million for Q3 2026, against a consensus estimate of $625 thousand. Crescent Biopharma Earnings HeadlinesCrescent Biopharma (NASDAQ:CBIO) Stock Gets Price Target Trim from Piper SandlerNovember 16 at 2:37 AM | americanbankingnews.comCrescent Biopharma (NASDAQ:CBIO) Price Target Raised to $40.00November 16 at 1:36 AM | americanbankingnews.comDrama In The Trade Rooms! (Black Friday deal to blame?)Base Camp Trading's Thomas Wood is giving away his proprietary Snapback Indicator for just $7 this Black Friday. Others paid $500 for it. It's a one-time price with no recurring billing, and the indicator is yours for life. It shows when it's time to sell or go short, and when it makes sense to buy. Check it for a potential Snapback before your next trade.November 19 at 1:00 AM | Base Camp Trading (Ad)Crescent Biopharma (NASDAQ:CBIO) Shares Gap Up on Analyst UpgradeNovember 15, 2026 | americanbankingnews.comCrescent Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 13, 2026 | marketscreener.comMCrescent Biopharma Reports Completion of CR-001 Dose Escalation, Initiation of CR-002 APOLLO Trial, and Third Quarter 2026 Financial ResultsNovember 12, 2026 | quiverquant.comQSee More Crescent Biopharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Crescent Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Crescent Biopharma and other key companies, straight to your email. Email Address About Crescent BiopharmaCrescent Biopharma (NASDAQ:CBIO) is a clinical-stage biotechnology company focused on developing medicines for cancer. Its research centers on antibody-based treatments, including therapies designed to target tumor cells and support the body’s immune response. The company’s work is directed toward advancing oncology drug candidates through clinical development. Its pipeline and programs may change as research progresses, and its products are investigational rather than established treatments. Crescent Biopharma is focused on developing its therapies for cancer patients; detailed information about its geographic operations and leadership is not included here.View Crescent Biopharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play ItLowe's Earnings Beat Looked Strong Until a 34-Cent Tariff Refund Changed the MathApple's Next Margin Defense Could Be Hiding in Your WalletThe Uranium Price Paradox: 5 Investments Facing Very Different Tests in 2027Target Stock Is Up Over 70%—Has the Easy Money Already Been Made? Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.